Lincoln [LINCOLN] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison
Lincoln
NSE
Loading...
Sequent Scientific
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lincoln wins in 17 metrics, Sequent Scientific wins in 2 metrics, with 0 ties. Lincoln appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lincoln | Sequent Scientific | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.69 | 151.50 | Lincoln |
| Price-to-Book Ratio | 1.63 | 6.18 | Lincoln |
| Debt-to-Equity Ratio | 0.00 | 62.47 | Lincoln |
| PEG Ratio | -1.08 | 1.27 | Lincoln |
| EV/EBITDA | 8.73 | 29.13 | Lincoln |
| Profit Margin (TTM) | 13.71% | 1.85% | Lincoln |
| Operating Margin (TTM) | 13.19% | 7.56% | Lincoln |
| EBITDA Margin (TTM) | 13.19% | 7.56% | Lincoln |
| Return on Equity | 12.26% | 2.84% | Lincoln |
| Return on Assets (TTM) | 10.33% | 1.37% | Lincoln |
| Free Cash Flow (TTM) | $737.71M | $442.73M | Lincoln |
| Dividend Yield | 0.31% | N/A | N/A |
| 1-Year Return | -17.29% | 22.66% | Sequent Scientific |
| Price-to-Sales Ratio (TTM) | 1.74 | 2.72 | Lincoln |
| Enterprise Value | $8.99B | $48.38B | Sequent Scientific |
| EV/Revenue Ratio | 1.43 | 3.02 | Lincoln |
| Gross Profit Margin (TTM) | 54.96% | 46.86% | Lincoln |
| Revenue per Share (TTM) | $315 | $64 | Lincoln |
| Earnings per Share (Diluted) | $43.08 | $1.15 | Lincoln |
| Beta (Stock Volatility) | 0.20 | 0.91 | Lincoln |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lincoln vs Sequent Scientific Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lincoln | -0.33% | -9.72% | -0.96% | -7.91% | -3.44% | -36.68% |
| Sequent Scientific | 2.48% | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lincoln | -17.29% | 85.49% | 121.31% | 152.16% | 152.16% | 152.16% |
| Sequent Scientific | 22.66% | 59.79% | 34.23% | 19.22% | 19.22% | 19.22% |
Performance & Financial Health Analysis: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Market Information | ||
| Market Cap | ₹10.98B | ₹43.54B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 589,540 | 724,877 |
| 90 Day Avg. Volume | 218,504 | 541,794 |
| Last Close | ₹542.65 | ₹175.77 |
| 52 Week Range | ₹499.00 - ₹979.50 | ₹117.35 - ₹240.70 |
| % from 52W High | -44.60% | -26.98% |
| All-Time High | ₹979.50 (Dec 09, 2024) | ₹336.50 (Jun 28, 2021) |
| % from All-Time High | -44.60% | -47.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.13% |
| Quarterly Earnings Growth | 0.17% | 1.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.02% |
| Operating Margin (TTM) | 0.13% | 0.08% |
| Return on Equity (TTM) | 0.12% | 0.03% |
| Debt to Equity (MRQ) | 0.00 | 62.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹335.40 | ₹28.19 |
| Cash per Share (MRQ) | ₹97.95 | ₹2.52 |
| Operating Cash Flow (TTM) | ₹967.87M | ₹360.47M |
| Levered Free Cash Flow (TTM) | ₹823.46M | ₹218.78M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.31% | N/A |
| Last 12-Month Dividend | ₹1.80 | ₹0.00 |
Valuation & Enterprise Metrics Analysis: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.69 | 151.50 |
| Forward P/E | N/A | 34.50 |
| PEG Ratio | -1.08 | 1.27 |
| Price to Sales (TTM) | 1.74 | 2.72 |
| Price to Book (MRQ) | 1.63 | 6.18 |
| Market Capitalization | ||
| Market Capitalization | ₹10.98B | ₹43.54B |
| Enterprise Value | ₹8.99B | ₹48.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.43 | 3.02 |
| Enterprise to EBITDA | 8.73 | 29.13 |
| Risk & Other Metrics | ||
| Beta | 0.20 | 0.91 |
| Book Value per Share (MRQ) | ₹335.40 | ₹28.19 |
Financial Statements Comparison: Lincoln vs Sequent Scientific
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Revenue/Sales | ₹1.68B | ₹4.41B |
| Cost of Goods Sold | ₹801.52M | ₹2.35B |
| Gross Profit | ₹880.31M | ₹2.07B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹234.93M | ₹333.50M |
| EBITDA | ₹198.39M | ₹505.30M |
| Pre-Tax Income | ₹162.47M | ₹255.20M |
| Income Tax | ₹46.72M | ₹79.50M |
| Net Income (Profit) | ₹115.75M | ₹175.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Cash & Equivalents | ₹134.14M | ₹626.60M |
| Total Current Assets | ₹5.00B | ₹8.74B |
| Total Current Liabilities | ₹1.06B | ₹5.05B |
| Long-Term Debt | N/A | ₹3.00B |
| Total Shareholders Equity | ₹6.72B | ₹7.70B |
| Retained Earnings | N/A | ₹1.25B |
| Property, Plant & Equipment | ₹1.82B | ₹2.84B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LINCOLN | SEQUENT |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 589,540 | 724,877 |
| Average Daily Volume (90 Day) | 218,504 | 541,794 |
| Shares Outstanding | 20.03M | 249.89M |
| Float Shares | 8.79M | 117.77M |
| % Held by Insiders | 0.55% | 0.53% |
| % Held by Institutions | 0.01% | 0.13% |
Dividend Analysis & Yield Comparison: Lincoln vs Sequent Scientific
| Metric | LINCOLN | SEQUENT |
|---|---|---|
| Last 12-Month Dividend | ₹1.80 | ₹0.00 |
| Last 12-Month Dividend Yield | 0.31% | N/A |
| 3-Year Avg Annual Dividend | ₹1.60 | ₹0.00 |
| 3-Year Avg Dividend Yield | 0.35% | N/A |
| 3-Year Total Dividends | ₹4.80 | ₹0.00 |
| Ex-Dividend Date | Sep 13, 2024 | N/A |